Key facts
- This page summarizes Elliott Robinson's Form 4 filing for Hinge Health, Inc. (HNGE).
- 10 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 13 Nov 2026, 06:15.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Additional SEC filing notes
Footnote F1
On November 9, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 6,474 and 6,077 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $119.57. These shares were sold in multiple transactions at prices ranging from $119.50 to $119.98. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Footnote F2
On November 9, 2026, BVP X and BVP X Inst sold 9,090 and 8,534 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $120.53. These shares were sold in multiple transactions at prices ranging from $120.01 to $120.99. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Footnote F3
On November 9, 2026, BVP X and BVP X Inst sold 18,471 and 17,339 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $121.13. These shares were sold in multiple transactions at prices ranging from $121.00 to $121.97. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Footnote F4
On November 9, 2026, BVP X and BVP X Inst sold 242 and 228 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $122.14. These shares were sold in multiple transactions at prices ranging from $122.14 to $122.14. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Footnote F5
On November 10, 2026, BVP X and BVP X Inst sold 3,028 and 2,842 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $120.61. These shares were sold in multiple transactions at prices ranging from $120.00 to $120.99. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Footnote F6
On November 10, 2026, BVP X and BVP X Inst sold 16,967 and 15,927 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $121.54. These shares were sold in multiple transactions at prices ranging from $121.00 to $121.91. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Footnote F7
On November 10, 2026, BVP X and BVP X Inst sold 3,287 and 3,086 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $122.70. These shares were sold in multiple transactions at prices ranging from $122.00 to $122.98. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Footnote F8
On November 10, 2026, BVP X and BVP X Inst sold 15,403 and 14,460 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $123.32. These shares were sold in multiple transactions at prices ranging from $123.01 to $123.74. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Footnote F9
On November 11, 2026, BVP X and BVP X Inst sold 6,214 and 5,833 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $124.76. These shares were sold in multiple transactions at prices ranging from $124.00 to $124.95. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Footnote F10
On November 11, 2026, BVP X and BVP X Inst sold 686 and 644 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $125.37. These shares were sold in multiple transactions at prices ranging from $125.00 to $125.90. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Footnote F11
The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities.